Novel blood-based protein signature determined for rare, aggressive lung cancer

Novel blood-based protein signature determined for rare, aggressive lung cancer

Researchers have discovered a panel of 13 blood proteins that may be effective biomarkers to detect malignant mesothelioma, according to a new study.